|
시장보고서
상품코드
2052193
북미의 동물용 조제 약국 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)North America Vet Compounding Pharmacies Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
북미의 동물용 조제 약국 시장은 맞춤형 동물용 의약품에 대한 수요 증가를 배경으로 꾸준히 성장하고 있습니다. 조제 약국은 대량 생산된 의약품으로 효과적으로 치료할 수 없는 동물을 위해 개별적인 용량과 제형을 준비하는 데 중요한 역할을 하고 있습니다. 시장 규모는 2026년 17억 달러에서 2033년 29억 달러로 성장하여 예측 기간 동안 CAGR 7.80%를 기록할 것으로 예상됩니다. 반려동물 사육두수의 증가, 수의학의 고도화, 동물 건강에 대한 인식의 증가가 업계 상황을 형성하는 주요 요인으로 작용하고 있습니다. 수의학 전문가들은 반려동물과 가축의 고유한 투약 요건을 충족하고, 복약 순응도를 높이고, 치료 결과를 개선하기 위해 조제 약국에 점점 더 의존하고 있습니다.
시장 인사이트:
이 시장은 의약품의 혁신과 수의학의 강력한 융합으로 진화하고 있습니다. 북미는 고도의 의료 인프라와 반려동물 의료에 대한 막대한 지출로 인해 여전히 매우 구조화된 시장으로 남아 있습니다. 동물의 통증 관리, 피부과, 호르몬 요법, 만성 질환 치료에서 조제 의약품의 사용이 증가하고 있습니다. 향이 첨가되거나 복용하기 쉬운 제형에 대한 선호도가 높아지면서 수요가 더욱 증가하고 있습니다. 약품 제제의 기술 발전과 엄격한 규제 감독도 약국 전체의 운영 기준을 형성하고 있습니다.
촉진요인:
주요 촉진요인으로는 반려동물 사육률 증가, 동물의 만성질환 유병률 증가, 반려동물의 '인간화' 추세의 증가 등을 꼽을 수 있습니다. 보호자들은 전문 치료에 대한 투자에 점점 더 적극적으로 투자하고 있으며, 이는 맞춤형 동물용 의약품에 대한 수요를 촉진하고 있습니다. 또한, 시판 중인 동물용 의약품의 부족으로 인해 수의사들은 조제를 통한 대안을 모색하고 있습니다. 동물병원 및 진료소 네트워크의 확대도 시장 성장에 기여하고 있습니다.
비즈니스 기회:
이 시장은 제약사 및 조제 약국에게 서비스 제공 범위를 확대할 수 있는 큰 성장 기회를 제공하고 있습니다. 디지털 처방 플랫폼과 원격 수의학 서비스는 새로운 유통 채널을 창출하고 있습니다. 자동 조제 시스템 및 품질 보증 기술에 대한 투자는 효율성과 확장성을 크게 향상시킬 수 있습니다. 수의사와 조제 약국과의 제휴가 늘어날 것으로 예상되며, 장기적인 사업 성장 전망이 열려있습니다.
지역 분석:
미국은 반려동물 사육두수가 많고 수의학 시스템이 발달되어 있어 북미 동물용 조제 약국 시장을 독점하고 있습니다. 캐나다에서도 동물 건강에 대한 인식이 높아지고 지원적인 규제 프레임워크에 힘입어 꾸준한 성장세를 보이고 있습니다. 특히 도시 지역에서는 반려동물 사육률이 높고, 수의학 서비스에 대한 접근성이 좋아 수요를 견인하고 있습니다. 이 지역은 강력한 R&D 투자와 전통 있는 제약기업의 존재로 인해 혜택을 받고 있습니다.
주요 기업:
- Hoye's Pharmacy
- Vertisis Custom Pharmacy
- Smith Caldwell Drug Store
- Sixth Avenue Medical Pharmacy
- Dougherty Pharmacy
- Triangle Compounding Pharmacy Inc.,
- Wedgewood Pharmacy
- Millers Pharmacy
- Chiron Compounding Pharmacy
- MEDS Canadian Compounding Pharmacy
시장 세분화
제품 유형별:
- 중추신경계 약물
- 항감염제
- 호르몬 및 호르몬 보충제
- 항염증제
- 기타
동물 유형별:
- 반려동물
- 가축
제형별:
- 경구
- 주사
- 기타
지역별:
- 북미
- 유럽
- 라틴아메리카
- 동아시아
- 남아시아 및 오세아니아
- 중동 및 아프리카
목차
제1장 주요 요약
제2장 시장 개요
제3장 북미의 동물용 조제 약국 시장 전망, 2020-2033년
제4장 북미의 동물용 조제 약국 시장 전망, 2020-2033년
제5장 유럽의 동물용 조제 약국 시장 전망, 2020-2033년
제6장 아시아태평양의 동물용 조제 약국 시장 전망, 2020-2033년
제7장 라틴아메리카의 동물용 조제 약국 시장 전망, 2020-2033년
제8장 중동 및 아프리카의 동물용 조제 약국 시장 전망, 2020-2033년
제9장 경쟁 구도
제10장 부록
KSM 26.06.11The North America vet compounding pharmacies market is witnessing steady expansion driven by rising demand for personalized veterinary medications. Compounding pharmacies play a critical role in preparing customized dosages and formulations for animals that cannot be treated effectively with mass-produced drugs. The market is projected to grow from US$ 1.7 Bn in 2026 to US$ 2.9 Bn by 2033, registering a CAGR of 7.80% during the forecast period. Increasing pet ownership, advanced veterinary care, and growing awareness of animal health are key factors shaping the industry landscape. Veterinary professionals increasingly rely on compounding pharmacies to address unique dosage requirements, improve compliance, and enhance therapeutic outcomes across companion and livestock animals.
Market Insights:
The market is evolving with strong integration of pharmaceutical innovation and veterinary science. North America remains a highly structured market due to advanced healthcare infrastructure and high expenditure on pet healthcare. Compounded medications are increasingly used for pain management, dermatology, hormonal therapies, and chronic disease treatment in animals. The growing preference for flavored and easy-to-administer formulations is further boosting demand. Technological advancements in drug formulation and stringent regulatory oversight are also shaping operational standards across pharmacies.
Drivers:
Key drivers include rising pet adoption rates, increasing prevalence of chronic diseases among animals, and a growing trend of humanization of pets. Owners are increasingly willing to invest in specialized treatments, fueling demand for customized veterinary drugs. Additionally, shortages of commercially available veterinary drugs are pushing veterinarians toward compounding alternatives. Expanding veterinary clinics and hospital networks also contribute to market growth.
Business Opportunity:
The market presents strong opportunities for pharmaceutical companies and compounding pharmacies to expand service offerings. Digital prescription platforms and tele-veterinary services are creating new distribution channels. Investments in automated compounding systems and quality assurance technologies can significantly improve efficiency and scalability. Partnerships between veterinarians and compounding pharmacies are expected to increase, creating long-term business growth prospects.
Region Analysis:
The United States dominates the North America vet compounding pharmacies market due to its large pet population and advanced veterinary healthcare system. Canada is also witnessing steady growth supported by increasing awareness of animal health and supportive regulatory frameworks. Urban regions are particularly driving demand due to higher pet ownership and better access to veterinary services. The region benefits from strong R&D investment and presence of established pharmaceutical companies.
Key Players:
- Hoye's Pharmacy
- Vertisis Custom Pharmacy
- Smith Caldwell Drug Store
- Sixth Avenue Medical Pharmacy
- Dougherty Pharmacy
- Triangle Compounding Pharmacy Inc.,
- Wedgewood Pharmacy
- Millers Pharmacy
- Chiron Compounding Pharmacy
- MEDS Canadian Compounding Pharmacy
Market Segmentation
By Product Type :
- CNS Agents
- Anti-infective Agents
- Hormones and Substitutes
- Anti-inflammatory Agents
- Others
By Animal Type :
- Companion Animals
- Livestock Animals
By Formulation :
- Oral
- Injectable
- Others
By Region :
- North America
- Europe
- Latin America
- East Asia
- South Asia and Oceania
- Middle East and Africa
Table of Contents
1. Executive Summary
- 1.1. Global North America Vet Compounding Pharmacies Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033
- 3.1. Global North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 3.1.1. CNS Agents
- 3.1.2. Anti-Infective Agents
- 3.1.3. Hormones and Substitutes
- 3.1.4. Anti-inflammatory Agents
- 3.2. Global North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 3.2.1. Companion Animals
- 3.2.1.1. Dogs
- 3.2.1.2. Cats
- 3.2.1.3. Others
- 3.2.2. Livestock Animals
- 3.2.1. Companion Animals
- 3.3. Global North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
- 3.3.1. Oral
- 3.3.2. Injectable
- 3.3.3. Others
- 3.4. Global North America Vet Compounding Pharmacies Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.4.1. North America
- 3.4.2. Europe
- 3.4.3. Asia Pacific
- 3.4.4. Latin America
- 3.4.5. Middle East & Africa
4. North America North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033
- 4.1. North America North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 4.1.1. CNS Agents
- 4.1.2. Anti-Infective Agents
- 4.1.3. Hormones and Substitutes
- 4.1.4. Anti-inflammatory Agents
- 4.2. North America North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 4.2.1. Companion Animals
- 4.2.1.1. Dogs
- 4.2.1.2. Cats
- 4.2.1.3. Others
- 4.2.2. Livestock Animals
- 4.2.1. Companion Animals
- 4.3. North America North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
- 4.3.1. Oral
- 4.3.2. Injectable
- 4.3.3. Others
- 4.4. North America North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.4.1. U.S. North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 4.4.2. U.S. North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 4.4.3. U.S. North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 4.4.4. Canada North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 4.4.5. Canada North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 4.4.6. Canada North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 4.5. BPS Analysis/Market Attractiveness Analysis
5. Europe North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033
- 5.1. Europe North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 5.1.1. CNS Agents
- 5.1.2. Anti-Infective Agents
- 5.1.3. Hormones and Substitutes
- 5.1.4. Anti-inflammatory Agents
- 5.2. Europe North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 5.2.1. Companion Animals
- 5.2.1.1. Dogs
- 5.2.1.2. Cats
- 5.2.1.3. Others
- 5.2.2. Livestock Animals
- 5.2.1. Companion Animals
- 5.3. Europe North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
- 5.3.1. Oral
- 5.3.2. Injectable
- 5.3.3. Others
- 5.4. Europe North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.4.1. Germany North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 5.4.2. Germany North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 5.4.3. Germany North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 5.4.4. Italy North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 5.4.5. Italy North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 5.4.6. Italy North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 5.4.7. France North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 5.4.8. France North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 5.4.9. France North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 5.4.10. U.K. North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 5.4.11. U.K. North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 5.4.12. U.K. North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 5.4.13. Spain North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 5.4.14. Spain North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 5.4.15. Spain North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 5.4.16. Russia North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 5.4.17. Russia North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 5.4.18. Russia North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 5.4.19. Rest of Europe North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 5.4.20. Rest of Europe North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 5.4.21. Rest of Europe North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 5.5. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033
- 6.1. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 6.1.1. CNS Agents
- 6.1.2. Anti-Infective Agents
- 6.1.3. Hormones and Substitutes
- 6.1.4. Anti-inflammatory Agents
- 6.2. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 6.2.1. Companion Animals
- 6.2.1.1. Dogs
- 6.2.1.2. Cats
- 6.2.1.3. Others
- 6.2.2. Livestock Animals
- 6.2.1. Companion Animals
- 6.3. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
- 6.3.1. Oral
- 6.3.2. Injectable
- 6.3.3. Others
- 6.4. Asia Pacific North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.4.1. China North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 6.4.2. China North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 6.4.3. China North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 6.4.4. Japan North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 6.4.5. Japan North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 6.4.6. Japan North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 6.4.7. South Korea North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 6.4.8. South Korea North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 6.4.9. South Korea North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 6.4.10. India North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 6.4.11. India North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 6.4.12. India North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 6.4.13. Southeast Asia North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 6.4.14. Southeast Asia North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 6.4.15. Southeast Asia North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 6.4.16. Rest of SAO North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 6.4.17. Rest of SAO North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 6.4.18. Rest of SAO North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 6.5. BPS Analysis/Market Attractiveness Analysis
7. Latin America North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033
- 7.1. Latin America North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 7.1.1. CNS Agents
- 7.1.2. Anti-Infective Agents
- 7.1.3. Hormones and Substitutes
- 7.1.4. Anti-inflammatory Agents
- 7.2. Latin America North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 7.2.1. Companion Animals
- 7.2.1.1. Dogs
- 7.2.1.2. Cats
- 7.2.1.3. Others
- 7.2.2. Livestock Animals
- 7.2.1. Companion Animals
- 7.3. Latin America North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
- 7.3.1. Oral
- 7.3.2. Injectable
- 7.3.3. Others
- 7.4. Latin America North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.4.1. Brazil North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 7.4.2. Brazil North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 7.4.3. Brazil North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 7.4.4. Mexico North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 7.4.5. Mexico North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 7.4.6. Mexico North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 7.4.7. Argentina North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 7.4.8. Argentina North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 7.4.9. Argentina North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 7.4.10. Rest of LATAM North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 7.4.11. Rest of LATAM North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 7.4.12. Rest of LATAM North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 7.5. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, 2020 - 2033
- 8.1. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 8.1.1. CNS Agents
- 8.1.2. Anti-Infective Agents
- 8.1.3. Hormones and Substitutes
- 8.1.4. Anti-inflammatory Agents
- 8.2. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Animal Type, Value (US$ Bn), 2020-2033
- 8.2.1. Companion Animals
- 8.2.1.1. Dogs
- 8.2.1.2. Cats
- 8.2.1.3. Others
- 8.2.2. Livestock Animals
- 8.2.1. Companion Animals
- 8.3. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Formulations, Value (US$ Bn), 2020-2033
- 8.3.1. Oral
- 8.3.2. Injectable
- 8.3.3. Others
- 8.4. Middle East & Africa North America Vet Compounding Pharmacies Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.4.1. GCC North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 8.4.2. GCC North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 8.4.3. GCC North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 8.4.4. South Africa North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 8.4.5. South Africa North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 8.4.6. South Africa North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 8.4.7. Egypt North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 8.4.8. Egypt North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 8.4.9. Egypt North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 8.4.10. Nigeria North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 8.4.11. Nigeria North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 8.4.12. Nigeria North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 8.4.13. Rest of Middle East North America Vet Compounding Pharmacies Market Outlook, by Product Type, 2020-2033
- 8.4.14. Rest of Middle East North America Vet Compounding Pharmacies Market Outlook, by Animal Type, 2020-2033
- 8.4.15. Rest of Middle East North America Vet Compounding Pharmacies Market Outlook, by Formulations, 2020-2033
- 8.5. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Hoye's Pharmacy
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Vertisis Custom Pharmacy
- 9.4.3. Smith Caldwell Drug Store
- 9.4.4. Sixth Avenue Medical Pharmacy
- 9.4.5. Dougherty Pharmacy
- 9.4.6. Triangle Compounding Pharmacy Inc.,
- 9.4.7. Wedgewood Pharmacy
- 9.4.8. Millers Pharmacy
- 9.4.9. Chiron Compounding Pharmacy
- 9.4.10. MEDS Canadian Compounding Pharmacy
- 9.4.1. Hoye's Pharmacy
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
(주말 및 공휴일 제외)
